Report cover image

PRP and PRF in Cosmetics Market (Type: Pure-PRP, Leukocyte-rich PRP, and Pure-PRF: and Origin: Autologous, Allogeneic, and Homologous) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Publisher Transparency Market Research Pvt. Ltd.
Published May 30, 2022
Length 179 Pages
SKU # TNPR17326553

Description

PRP and PRF in Cosmetics Market (Type: Pure-PRP, Leukocyte-rich PRP, and Pure-PRF: and Origin: Autologous, Allogeneic, and Homologous) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Companies Mentioned

Stryker Corporation
Croma-Pharma GmbH
Zimmer Biomet
Isto Biologics
Exactech, Inc.
EmCyte Corporation
Regen Lab
APEX Biologix
ThermoGenesis Holdings, Inc.

Countries

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Forecast Year (first) - 2022

Forecast Year (last) - 2031

Forecast Year ( first)  Value - 150

Forecast Year (last) Value - 483

CAGR % - 0.126

Currency - US$ Mn

Table of Contents

179 Pages
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global PRP and PRF in Cosmetics
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global PRP and PRF in Cosmetics Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Installed Base Scenario (2019)
5.1.1. Installed Base Scenario
5.1.1.1. By Type
5.1.1.2. By Origin Type
5.1.1.3. By Region
5.1.1.4. By Major Players
5.1.2. New versus Replacement Unit Shipments
5.2. Export-Import Scenario
5.2.1. Export-Import Scenario by Region
5.3. Price Comparison Analysis (2019)
5.3.1. By Type
5.3.2. By Origin Type
5.3.3. By Region
5.3.4. By Major Players
5.4. Key Potential Customers
5.4.1. Key Potential Customers by Region
5.5. Key Vendor and Distributor Analysis
5.5.1. Key Vendor Analysis by Major Players
5.5.2. Key Distributor Analysis by Major Players
5.6. Technological Advancements
5.7. Regulatory Scenario, by Region/globally
5.8. Key Industry Events (mergers, acquisitions, partnerships, etc.)
5.9. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global PRP and PRF in Cosmetics Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. Pure-PRP
6.3.2. Leukocyte-rich PRP
6.3.3. Pure-PRF
6.4. Market Attractiveness Analysis, by Type
7. Global PRP and PRF in Cosmetics Analysis and Forecast, by Origin
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Origin, 2017–2031
7.3.1. Autologous
7.3.2. Allogeneic
7.3.3. Homologous
7.3.4. Others
7.4. Market Attractiveness Analysis, by Origin
8. Global PRP and PRF in Cosmetics Analysis and Forecast, by Cosmetic Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Cosmetic Application, 2017–2031
8.3.1. Skin Rejuvenation
8.3.2. Face Lift
8.3.3. Hair Application
8.3.4. Plastic Surgery
8.3.5. Scar-related Treatment
8.3.6. Others
8.4. Market Attractiveness Analysis, by Cosmetic Application
9. Global PRP and PRF in Cosmetics Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness By Country/Region
10. North America PRP and PRF in Cosmetics Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017–2031
10.2.1. Pure-PRP
10.2.2. Leukocyte-rich PRP
10.2.3. Pure-PRF
10.3. Market Value Forecast, by Origin, 2017–2031
10.3.1. Autologous
10.3.2. Allogeneic
10.3.3. Homologous
10.3.4. Others
10.4. Market Value Forecast, by Cosmetic Application, 2017–2031
10.4.1. Skin Rejuvenation
10.4.2. Face Lift
10.4.3. Hair Application
10.4.4. Plastic Surgery
10.4.5. Scar-related Treatment
10.4.6. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Origin
10.6.3. By Cosmetic Application
10.6.4. By Country
11. Europe PRP and PRF in Cosmetics Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2031
11.2.1. Pure-PRP
11.2.2. Leukocyte-rich PRP
11.2.3. Pure-PRF
11.3. Market Value Forecast, by Origin, 2017–2031
11.3.1. Autologous
11.3.2. Allogeneic
11.3.3. Homologous
11.3.4. Others
11.4. Market Value Forecast, by Cosmetic Application, 2017–2031
11.4.1. Skin Rejuvenation
11.4.2. Face Lift
11.4.3. Hair Application
11.4.4. Plastic Surgery
11.4.5. Scar-related Treatment
11.4.6. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Origin
11.6.3. By Cosmetic Application
11.6.4. By Country/Sub-region
12. Asia Pacific PRP and PRF in Cosmetics Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2031
12.2.1. Pure-PRP
12.2.2. Leukocyte-rich PRP
12.2.3. Pure-PRF
12.3. Market Value Forecast, by Origin, 2017–2031
12.3.1. Autologous
12.3.2. Allogeneic
12.3.3. Homologous
12.3.4. Others
12.4. Market Value Forecast, by Cosmetic Application, 2017–2031
12.4.1. Skin Rejuvenation
12.4.2. Face Lift
12.4.3. Hair Application
12.4.4. Plastic Surgery
12.4.5. Scar-related Treatment
12.4.6. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. Japan
12.5.2. China
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Origin
12.6.3. By Cosmetic Application
12.6.4. By Country/Sub-region
13. Latin America PRP and PRF in Cosmetics Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017–2031
13.2.1. Pure-PRP
13.2.2. Leukocyte-rich PRP
13.2.3. Pure-PRF
13.3. Market Value Forecast, by Origin, 2017–2031
13.3.1. Autologous
13.3.2. Allogeneic
13.3.3. Homologous
13.3.4. Others
13.4. Market Value Forecast, by Cosmetic Application, 2017–2031
13.4.1. Skin Rejuvenation
13.4.2. Face Lift
13.4.3. Hair Application
13.4.4. Plastic Surgery
13.4.5. Scar-related Treatment
13.4.6. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Origin
13.6.3. By Cosmetic Application
13.6.4. By Country/Sub-region
14. Middle East & Africa PRP and PRF in Cosmetics Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017–2031
14.2.1. Pure-PRP
14.2.2. Leukocyte-rich PRP
14.2.3. Pure-PRF
14.3. Market Value Forecast, by Origin, 2017–2031
14.3.1. Autologous
14.3.2. Allogeneic
14.3.3. Homologous
14.3.4. Others
14.4. Market Value Forecast, by Cosmetic Application, 2017–2031
14.4.1. Skin Rejuvenation
14.4.2. Face Lift
14.4.3. Hair Application
14.4.4. Plastic Surgery
14.4.5. Scar-related Treatment
14.4.6. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Origin
14.6.3. By Cosmetic Application
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Market Footprint Analysis
15.3.1. By Region
15.3.2. By Type
15.4. Competitive Business Strategies
15.5. Company Profiles
15.5.1. Stryker Corporation
15.5.1.1. Company Overview
15.5.1.2. Financial Overview
15.5.1.3. Product Portfolio
15.5.1.4. Business Strategies
15.5.2. Croma-Pharma GmbH
15.5.2.1. Company Overview
15.5.2.2. Financial Overview
15.5.2.3. Product Portfolio
15.5.2.4. Business Strategies
15.5.3. Zimmer Biomet
15.5.3.1. Company Overview
15.5.3.2. Financial Overview
15.5.3.3. Product Portfolio
15.5.3.4. Business Strategies
15.5.4. Isto Biologics
15.5.4.1. Company Overview
15.5.4.2. Financial Overview
15.5.4.3. Product Portfolio
15.5.4.4. Business Strategies
15.5.5. Exactech, Inc.
15.5.5.1. Company Overview
15.5.5.2. Financial Overview
15.5.5.3. Product Portfolio
15.5.5.4. Business Strategies
15.5.6. EmCyte Corporation
15.5.6.1. Company Overview
15.5.6.2. Financial Overview
15.5.6.3. Product Portfolio
15.5.6.4. Business Strategies
15.5.7. Regen Lab
15.5.7.1. Company Overview
15.5.7.2. Financial Overview
15.5.7.3. Product Portfolio
15.5.7.4. Business Strategies
15.5.8. APEX Biologix
15.5.8.1. Company Overview
15.5.8.2. Financial Overview
15.5.8.3. Product Portfolio
15.5.8.4. Business Strategies
15.5.9. ThermoGenesis Holdings, Inc.
15.5.9.1. Company Overview
15.5.9.2. Financial Overview
15.5.9.3. Product Portfolio
15.5.9.4. Business Strategies

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us